The Pennant Group, Inc. (PNTG) reported $209.84 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 33.7%. EPS of $0.27 for the same period compares to $0.20 a year ago.
The reported revenue represents a surprise of +3.68% over the Zacks Consensus Estimate of $202.4 million. With the consensus EPS estimate being $0.22, the EPS surprise was +22.73%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how The Pennant Group performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Total home health and hospice services: $159.87 million compared to the $151.45 million average estimate based on two analysts. The reported number represents a change of +37.2% year over year.
- Revenue- Senior living services: $49.97 million compared to the $47.98 million average estimate based on two analysts. The reported number represents a change of +23.6% year over year.
- Revenue- Home health and hospice services- Home care and other: $15.17 million versus $12.57 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +224.7% change.
- Revenue- Home health and hospice services- Hospice: $70.59 million versus the two-analyst average estimate of $68.61 million. The reported number represents a year-over-year change of +29.3%.
- Revenue- Home health and hospice services- Home health: $74.12 million versus $70.28 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +29.6% change.
View all Key Company Metrics for The Pennant Group here>>>
Shares of The Pennant Group have returned +9.8% over the past month versus the Zacks S&P 500 composite's +11.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Pennant Group, Inc. (PNTG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
